SXI Life Sciences
6.963,36
PKT
-12,54
PKT
-0,18
%
Werbung
Analysen zu SXI Life Sciences-Werten
| Datum | Rating | Analyst | |
|---|---|---|---|
| 11.05.20 | Novartis Neutral | UBS AG | |
| 08.05.20 | Novartis Underweight | JP Morgan Chase & Co. | |
| 05.05.20 | Novartis Conviction Buy List | Goldman Sachs Group Inc. | |
| 30.04.20 | Novartis Hold | HSBC | |
| 30.04.20 | Roche Hold | HSBC | |
| 29.04.20 | Novartis Neutral | Credit Suisse Group | |
| 29.04.20 | Novartis Underweight | JP Morgan Chase & Co. | |
| 28.04.20 | Roche buy | UBS AG | |
| 28.04.20 | Novartis Neutral | UBS AG | |
| 28.04.20 | Novartis Conviction Buy List | Goldman Sachs Group Inc. | |
| 28.04.20 | Novartis Underweight | JP Morgan Chase & Co. | |
| 28.04.20 | Novartis buy | Jefferies & Company Inc. | |
| 27.04.20 | Roche overweight | Morgan Stanley | |
| 24.04.20 | Novartis Underweight | JP Morgan Chase & Co. | |
| 24.04.20 | Roche Conviction Buy List | Goldman Sachs Group Inc. | |
| 23.04.20 | Roche buy | UBS AG | |
| 23.04.20 | Roche overweight | JP Morgan Chase & Co. | |
| 23.04.20 | Roche Neutral | Credit Suisse Group | |
| 22.04.20 | Roche overweight | JP Morgan Chase & Co. | |
| 22.04.20 | Roche Conviction Buy List | Goldman Sachs Group Inc. | |
| 22.04.20 | Roche buy | Jefferies & Company Inc. | |
| 20.04.20 | Novartis Conviction Buy List | Goldman Sachs Group Inc. | |
| 17.04.20 | Roche overweight | JP Morgan Chase & Co. | |
| 16.04.20 | Roche overweight | JP Morgan Chase & Co. | |
| 15.04.20 | Roche buy | Jefferies & Company Inc. | |
| 15.04.20 | Novartis buy | Jefferies & Company Inc. | |
| 09.04.20 | Roche overweight | Barclays Capital | |
| 07.04.20 | Roche Conviction Buy List | Goldman Sachs Group Inc. | |
| 07.04.20 | Novartis Conviction Buy List | Goldman Sachs Group Inc. | |
| 07.04.20 | Novartis Underweight | JP Morgan Chase & Co. | |
| 06.04.20 | Novartis Hold | Deutsche Bank AG | |
| 06.04.20 | Roche buy | Deutsche Bank AG | |
| 03.04.20 | Roche overweight | Barclays Capital | |
| 02.04.20 | Novartis Conviction Buy | Goldman Sachs Group Inc. | |
| 01.04.20 | Roche overweight | JP Morgan Chase & Co. | |
| 01.04.20 | Novartis buy | Jefferies & Company Inc. | |
| 31.03.20 | Novartis buy | Oddo BHF | |
| 31.03.20 | Roche buy | Oddo BHF | |
| 30.03.20 | Roche overweight | JP Morgan Chase & Co. | |
| 24.03.20 | Roche buy | UBS AG |